Insights into Weight loss therapy: CDX2 inhibits hepatic steatosis and promotes weight loss via down regulation of Nocturnin, 27/February/2015, 8.56 am

Molecular therapy for weight loss: ING1b decreases the expression of Low density lipoprotein receptor-related protein 6 and promotes weight loss via up regulation of its target gene, 27/February/2015, 8.46 am
February 27, 2015
Natural product-based therapy for Emphysema: Fisetin, a flavonoid enriched in strawberries, Mangoes and Cucumber, inhibits inflammation and protects against Emphysema via up regulation of its target gene, 27/February/2016, 9.01 am
February 27, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Insights into Weight loss therapy: CDX2 inhibits hepatic steatosis and promotes weight loss via down regulation of Nocturnin, 27/February/2015, 8.56 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Significance:  CDX2, by increasing the expression of its target gene, it may decrease the expression of Nocturnin, and promote weight loss.  Thus, pharmacological formulations encompassing “CDX2 activators  may be used to promote weight loss.
Undisclosed information: How CDX2 suppresses the expression of Nocturnin
Amount: $300*
* Research cooperation

Comments are closed.